Seattle, May 22, 2013 - Cardeas Pharma Corporation, a biopharmaceutical company focused on the development of innovative therapies for the treatment of multi-drug resistant (MDR) bacterial infections, ...
Treatment of lung diseases with inhaled medications is a challenge for mechanically ventilated patients, especially for the youngest ones. Therapeutic effects are thought to be limited by the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback